Health Care Eli Lilly (LLY) Earnings: 3Q25 Key Numbers 3 months ago Eli Lilly and Company (NYSE: LLY) reported its third quarter 2025 earnings results today. Worldwide revenue was $17.60 billion, up… Key highlights from Merck’s (MRK) Q3 2025 earnings results 3 months ago Merck & Co., Inc. (NYSE: MRK) reported its third quarter 2025 earnings results today. Total worldwide sales of $17.3 billion… UnitedHealth Group’s Q3 2025 earnings fall despite double-digit revenue growth 3 months ago Healthcare behemoth UnitedHealth Group (NYSE: UNH) announced results for the third quarter of fiscal 2025, reporting an increase in revenues… Earnings Summary: HCA Healthcare Q3 adj. profit jumps on strong revenue growth 3 months ago Health services behemoth HCA Healthcare, Inc. (NYSE: HCA) has reported a sharp increase in adjusted earnings for the third quarter… Earnings Summary: A snapshot of Revvity’s (RVTY) Q3 2025 report 3 months ago Revvity, Inc. (NYSE: RVTY), a provider of health science solutions and technologies, reported a decline in adjusted earnings for the… Earnings Summary: Highlights of Boston Scientific’s Q3 2025 results 3 months ago Medical device maker Boston Scientific Corporation (NYSE: BSX) on Wednesday reported financial results for the third quarter of 2025. The company… Intuitive Surgical (ISRG) Q3 FY25 revenue and earnings beat estimates 3 months ago Medical device company Intuitive Surgical, Inc. (NASDAQ: ISRG) on Wednesday reported stronger-than-expected revenue and earnings for the third quarter of… Infographic: How Thermo Fisher (TMO) performed in Q3 2025 3 months ago Thermo Fisher Scientific Inc. (NYSE: TMO) reported its third quarter 2025 earnings results today. Revenue grew 5% year-over-year to $11.12… Abbott Laboratories Q3 adj. earnings rise on higher sales; meet Street view 4 months ago Abbott Laboratories (NYSE: ABT) reported higher sales and adjusted earnings for the third quarter of fiscal 2025. The healthcare company… Kairos Pharma’s goal is to intervene early in resistance and re-sensitize cancer cells to therapy: CEO 4 months ago Kairos Pharma, Ltd. (NYSE: KAPA) is a biopharma company developing a pipeline of targeted therapies for cancer patients with high… Next» « Previous